Shopping Cart
Remove All
Your shopping cart is currently empty
Givosiran (ALN-AS1) is a small interfering RNA (siRNA) compound that specifically targets hepatic aminolevulinate synthase 1 (ALAS1) messenger RNA (mRNA) to downregulate its expression, thereby inhibiting the accumulation of neurotoxic δ-aminolevulinic acid and porphobilinogen levels, with significant potential for further research on acute intermittent porphyria.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $242 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $630 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $983 | 2-4 weeks | 2-4 weeks | |
| 25 mg | $1,970 | 2-4 weeks | 2-4 weeks | |
| 50 mg | $3,150 | 2-4 weeks | 2-4 weeks | |
| 100 mg | $5,030 | 2-4 weeks | 2-4 weeks |
| Description | Givosiran (ALN-AS1) is a small interfering RNA (siRNA) compound that specifically targets hepatic aminolevulinate synthase 1 (ALAS1) messenger RNA (mRNA) to downregulate its expression, thereby inhibiting the accumulation of neurotoxic δ-aminolevulinic acid and porphobilinogen levels, with significant potential for further research on acute intermittent porphyria. |
| In vitro | Givosiran is conjugated to a trivalent N-acetylgalactosamine ligand for specific binding to the asialoglycoprotein receptor, facilitating targeted hepatocyte delivery[2]. |
| Synonyms | Givosiran, ALN-AS1 |
| Cas No. | 1639325-43-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.